Dr. Ajay Sasidharan

Dr. Ajay Sasidharan is currently working as Clinical Assistant Professor in the Department of Radiation Oncology at Amrita Institute of Medical Sciences. He completed his MBBS in 2011 from Bangalore Medical College and Research Institute (Rajiv Gandhi University of Health Sciences) and MD Radiation Oncology in 2016 from Tata Memorial Centre, Mumbai (Homi Bhabha National Institute). He did further training as Senior Resident in Tata Memorial Centre from 2016 till 2019. He has co-authored publications in national and international journals.

Education and Professional Experience :

2021 March : Diplomate of National Board (DNB) in Radiation Oncology, from National Board of Examinations, New Delhi.

2019 September : Joined as Clinical Assistant Professor, Department of Radiation Oncology, Amrita Institute of Medical Sciences, Kochi.

2016 September – 2019 August : Senior Resident, Department of Radiation Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai.

2016 August : Doctor of Medicine (MD) in Radiation Oncology from Tata Memorial Centre.

2013 August – 2016 August : Junior Resident, Department of Radiation Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai.

2011 March – 2012 March : Rotatory Internship, Bangalore Medical College and Research Institute, Rajiv Gandhi University of Health Sciences.

2006 – 2011 February : MBBS, Bangalore Medical College and Research Institute, Rajiv Gandhi University of Health Sciences.

Professional Memberships :

Association of Radiation Oncologists of India (AROI)

Indian Brachytherapy Society (IBS)

The Royal College of Radiologists (RCR)

Professional Interest :

Breast and Gynecological Cancers, Uro-Oncology, Neuro-Oncology, Sarcomas, Lymphomas, Gastrointestinal Cancers, Head and Neck Cancers.

High Dose Rate Intracavitary and Interstitial Brachytherapy.

Intensity Modulated Radiotherapy (IMRT), Volumetric Modulated Arc Therapy (VMAT).

Stereotactic Body Radiotherapy (SBRT), Stereotactic Radiosurgery (SRS).

Publications :

Original Articles :

Sasidharan A, Hande V, Mahantshetty U, Shrivastava SK. Cardiac metastasis in cervical cancer. BJR Case Rep. 2016; 2: 20150300. doi: 10.1259/bjrcr.20150300

A. Sasidharan, T. Wadasadawala. Intra medullary Spinal Cord Metastasis from Carcinoma Breast treated with Palliative Radiotherapy– A Report of Four Cases. BAOJ Cancer Res Ther. 2017; 3: 031.

Sasidharan A, Krishnatry R. Molecular insights turning game for management of ependymoma: A review of literature. Cancer Translational Medicine, 2018; 4(5), p.123.

Mahantshetty U, Gudi S, Singh R, Sasidharan A, Sastri SC, Gurram L, Sharma D, Ganeshrajah S, Mg J, Badakh D, Basu A, James F, Swamidas JV, Kuppuswamy T, Bhalavat R. Indian Brachy-therapy Society Guidelines for radiotherapeutic management of cervical cancer with special emphasis on high-dose-rate brachytherapy. J Contemp Brachytherapy. 2019; 11(4): 293-306. doi: 10.5114/jcb.2019.87406. Epub 2019 Aug 29.

Sasidharan A, Mahanthsetty U, Gurram L, Chopra S, Engineer R, Maheshwari A, Gupta S, Deo-dhar K, Rangarajan V, Thakur M, Shrivastava S. Patterns of First Relapse and Outcome in Pa-tients with Locally Advanced Cervical Cancer After Radiochemotherapy: A Single Institutional Experience. Indian J Gynecol Oncolog (2020) 18: 4. https://doi.org/10.1007/s40944-019-0345-7.

Sasidharan A, Verma A, Epari S, Gupta T, Laskar S, Khanna N, et al. Symptomatic intracranial rosai-dorfman disease in the suprasellar region treated with conformal radiotherapy – A report of two cases and literature review. Neurol India 2020;68:489-92.

Sasidharan A, Murthy V, Natarajan A, Agarwal A, Ranagrajan V, Gudi S, Singh S, Popat P. Pilot Study comparing dominant intraprostatic lesion volume using Ga-68 prostate-specific membrane antigen PET-computed tomography and multiparametric MRI. Nucl Med Commun. 2020;41(12):1291-1298.

Dutta D, Kataki KJ, George S, Reddy KS, Sashidharan A, Kannan R, Madhavan R, Nair H, Ta-tineni T, Holla R. Prospective evaluation of fiducial marker placement quality and toxicity in liver CyberKnife stereotactic body radiotherapy. Radiat Oncol J. 2020;38(4):253-261.

Jose M, Pottikyal GS, Sasidharan A, Kavalagunta S, Haridas AE, Dutta D. Unusual presentation of an extrahepatic migration of a fiducial implanted for stereotactic body radiotherapy. Jour of Radiosurgery and SBRT. 2021, Vol 0, pp-1-4.

Conference Proceedings :

A. Sasidharan, N. Khanna, T. Vora, J. Bajpai, S. Shah, N. Purandare, M. Ramadwar, S. Kembhavi, A. Gulia, B. Rekhi, S. Juvekar, S. Qureshi, A. Puri, S. Laskar. Metastatic PNET treat-ed with curative intent. Miscellaneous. J Can Res Ther 2016;12:81-6

Sasidharan A, Mahanthsetty U, Engineer R, et al. Outcome after first relapse in patients with locally advanced cervical cancer treated with radical radio (chemo) therapy. Int J Radiat Oncol Biol Phys 2016;96:E293.

N. Khanna, A. Sasidharan, T. Vora, J. Bajpai, S. Shah, N. Purandare, M. Ramadwar, S. Kembhavi, A. Gulia, B. Rekhi, S. Juvekar, S. Qureshi, A. Puri, S. Laskar. Outcomes of Ewing Sarcoma with limited metastatic disease treated with curative intent. Thegreenjournal.com. (2018).[online] Available at: https://www.thegreenjournal.com/article/S0167-8140(18)31936-4/pdf.

S.Laskar, A. Sasidharan, N. Khanna, R. Singh, G. Chinnaswamy, T. Vora, S.Qureshi, M. Ramadwar, S. Kembhavi, S. Shah, M. Prasad, A. Baheti, M. Muckaden, Purna Kurkure. Head and Neck (H&N) Rhabdomyosarcoma: Outcomes of Patients with Low and Intermediate Risk Disease. SIOP ABSTRACTS. (2018). Pediatric Blood & Cancer, 65, p.e27455.

Murthy V, Sasidharan A, Natarajan A, Popat P, Gudi S, Singh S, Agarwal A, Rangarajan V. Cor-relating Ga68-PSMA PET-CT with mpMRI to define Dominant Intraprostatic Lesion for focal ra-diotherapy boost planning. EUR Urol Suppl 2018;17(13);e2759

Sasidharan A, Kataki K, Shibu G, Kannan R, Madhavan R, Tarani T, Dutta D. Prospective evalu-ation of fiducial migration after placement for liver SBRT and influence on treatment delivery. J Cancer Res Ther. Volume 15, Supplement Issue 2 – 2019.

Current Project:

Prospective Study analysing skin toxicity, quality of life and cosmesis with hypofractionated radiation therapy in early breast cancer.